End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if DOCT is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
1 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
108 filers reported a long position in DOCT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| OPPENHEIMER & CO INC | $18.7M | 400.9K | +0.7% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | $13.3M | 284.4K | -0.6% |
| REAP Financial Group, LLC | $10M | 215.3K | -2.4% |
| ENVESTNET ASSET MANAGEMENT INC | $9.9M | 211.2K | +41.1% |
| Wood Tarver Financial Group, LLC | $8.3M | 176.9K | -25.8% |
| Per Stirling Capital Management, LLC. | $6.7M | 143.1K | +5.1% |
| Mutual Advisors, LLC | $6.5M | 138.5K | -4% |
| LCNB CORP | $5.7M | 122.3K | -3.8% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.4M | 115.6K | New |
| WINNACLE WEALTH LLC | $5.1M | 109.6K | -3.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.